GreenBone Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 16

Employees
  • Latest Deal Type

  • Series B

  • Latest Deal Amount

  • $11.9M

  • Investors

  • 8

GreenBone General Information

Description

Developer of biomimetic bone implants designed to treat severe fractures and conditions such as trauma and tumors that result in extensive bone loss. The company's implants transform bamboo wood into an established, widely used biomaterial called hydroxyapatite to serve as a bone graft scaffold that features weight-bearing and bone regeneration properties needed for large implants, enabling patients to get to use bio-inspired methods that will help cure severe diseases.

Contact Information

Website
www.greenbone.it
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Via Albert Einstein 8
  • 48018 Faenza
  • Italy

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GreenBone Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 12-Apr-2021 $11.9M 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 16-Jun-2017 00.00 000.00 Completed Product Development
1. Seed Round 18-Sep-2015 $3.37M $3.37M Completed Startup
To view GreenBone’s complete valuation and funding history, request access »

GreenBone Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biomimetic bone implants designed to treat severe fractures and conditions such as trauma and tumors that r
Therapeutic Devices
Faenza, Italy
16 As of 2022
000.00
00000000000 000.00

000000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostr
00000000000 0000000
Helotes, TX
00 As of 0000
00.000
000000000000 00.000

000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
0000000 00000000
Vigneux-de-Bretage, France
00 As of 0000
00.000
00 0000-00-00
000000&0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GreenBone Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Metric (Therapeutic Devices) Venture Capital-Backed Helotes, TX 00 00.000 000000000000 00.000
00000000000 Formerly VC-backed Vigneux-de-Bretage, France 00 00.000 000000&0 00.000
000000 0000000000 Venture Capital-Backed Overland Park, KS 00 0000 000000 - 000 0000
00000000 000000000 Venture Capital-Backed Grand Rapids, MI 00 000.00 0000000000 0 000.00
000000000 00000000 Formerly PE-Backed El Dorado Hills, CA 00 000.00 000000&0 000.00
You’re viewing 5 of 22 competitors. Get the full list »

GreenBone Patents

  • 28

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

GreenBone Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210316263-A1 System for chemical transformation of 3d state materials Pending 09-Aug-2018 000000000
AU-2019320452-A1 System for chemical transformation of 3d state materials Pending 09-Aug-2018 000000000
CA-3108367-A1 System for chemical transformation of 3d state materials Pending 09-Aug-2018 000000000
EP-3833469-A1 System for chemical transformation of 3d state materials Pending 09-Aug-2018 000000000
AU-2016304431-A1 Large 3d porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them Active 06-Aug-2015 A61L27/12
To view GreenBone’s complete patent history, request access »

GreenBone Executive Team (7)

Name Title Board Seat Contact Info
Stefano Di Lullo Chief Executive Officer
Saverio Gellini President
Diego Ferrari Chief Financial Officer
Andrea Cha Co-Chief Operating Officer
Susanna Salvagno Chief Medical Officer & Chief Scientific Officer
You’re viewing 5 of 7 executive team members. Get the full list »

GreenBone Board Members (7)

Name Representing Role Since
Alastair Clemow Ph.D Self Board Member 000 0000
Claudio Giuliano Innogest Capital Chairman 000 0000
Diogo Moreira-Rato Self Board Member 000 0000
Francesca Natali META Group Board Member 000 0000
Francesco Granata MD 3B Future Health Ventures Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

GreenBone Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GreenBone Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
META Group Venture Capital Minority 000 0000 000000 0
3B Future Health Ventures Venture Capital Minority 000 0000 000000 0
B-Engine Venture Capital Minority 000 0000 000000 0
CDP Venture Capital Venture Capital Minority 000 0000 000000 0
Helsinn Healthcare Corporation Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial